Annual report [Section 13 and 15(d), not S-K Item 405]

Restatement of Quarterly Financial Information (Unaudited) - Condensed Consolidated Statements of Operations (Parenthetical) (Details)

v3.25.1
Restatement of Quarterly Financial Information (Unaudited) - Condensed Consolidated Statements of Operations (Parenthetical) (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Quarterly Financial Data Item [Line Item]    
Cash and cash equivalents $ 19,206 $ 29,136
Contract assets 785 4,718
Other current assets 3,278 16,848
Property and equipment, net 63,338 60,446
Other long-term assets, including restricted cash 2,109 8,380
Other accrued expenses 1,215 927
Contract liabilities, current portion 22,037 31,178
Contract liabilities, non-current portion 23,489 17,923
Deferred income tax liabilities 860 804
Other long-term liabilities 8 8
Accumulated other comprehensive income (loss) (9,770) (4,556)
Accumulated deficit (538,104) (435,286)
Revenue (110,451) (97,612)
Cost of revenue 70,560 59,024
Research and development 29,188 27,650
General and administrative 49,744 41,999
Other expense, net (1,912) (2,272)
Foreign currency gain or loss 4,314 (1,524)
Income tax provision (benefit) $ 159 $ (142)